Search details
1.
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.
Mol Cancer
; 23(1): 78, 2024 Apr 20.
Article
in English
| MEDLINE | ID: mdl-38643157
2.
Special Issue "From Basic Science to Treatment Strategies: Personalized Cancer Therapy".
Int J Mol Sci
; 25(3)2024 Jan 24.
Article
in English
| MEDLINE | ID: mdl-38338712
3.
Molecular Targeting of the BRAF Proto-Oncogene/Mitogen-Activated Protein Kinase (MAPK) Pathway across Cancers.
Int J Mol Sci
; 25(1)2024 Jan 03.
Article
in English
| MEDLINE | ID: mdl-38203795
4.
NTRK Therapy among Different Types of Cancers, Review and Future Perspectives.
Int J Mol Sci
; 25(4)2024 Feb 17.
Article
in English
| MEDLINE | ID: mdl-38397049
5.
Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing.
BMC Cancer
; 23(1): 1000, 2023 Oct 18.
Article
in English
| MEDLINE | ID: mdl-37853341
6.
TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors.
Future Oncol
; 19(2): 123-135, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36877099
7.
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Oncologist
; 2022 May 10.
Article
in English
| MEDLINE | ID: mdl-35536733
8.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Article
in English
| MEDLINE | ID: mdl-29466156
9.
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building.
Curr Oncol Rep
; 23(6): 64, 2021 04 14.
Article
in English
| MEDLINE | ID: mdl-33855620
10.
Lung Cancer in the Young.
Lung
; 198(1): 195-200, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31773258
11.
Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America.
Oncology
; 96(4): 207-216, 2019.
Article
in English
| MEDLINE | ID: mdl-30476928
12.
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types.
Biochem Biophys Res Commun
; 500(3): 621-625, 2018 06 07.
Article
in English
| MEDLINE | ID: mdl-29679564
13.
New targets bring hope in squamous cell lung cancer: neurotrophic tyrosine kinase gene fusions.
Lab Invest
; 97(11): 1268-1270, 2017 11.
Article
in English
| MEDLINE | ID: mdl-29085074
14.
Anaphylactic Shock and Cardiac Arrest Secondary to Aprepitant.
Am J Ther
; 27(6): e640-e642, 2020.
Article
in English
| MEDLINE | ID: mdl-32796161
15.
Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines.
Curr Oncol Rep
; 16(9): 400, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-25030654
16.
Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the art.
Semin Immunol
; 22(3): 105-12, 2010 Jun.
Article
in English
| MEDLINE | ID: mdl-20226686
17.
Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population.
Cancers (Basel)
; 16(6)2024 Mar 14.
Article
in English
| MEDLINE | ID: mdl-38539485
18.
Genomic ancestry and cancer among Latin Americans.
Clin Transl Oncol
; 2024 Apr 06.
Article
in English
| MEDLINE | ID: mdl-38581481
19.
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 8: e2300371, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38330261
20.
Importance of ROS1 gene fusions in non-small cell lung cancer.
Cancer Drug Resist
; 6(2): 332-344, 2023.
Article
in English
| MEDLINE | ID: mdl-37457125